Skip to main content

Inflection Point Acquisition Corp. VII

corporate_fare Company Profile

Inflection Point Acquisition Corp. VII

IPXG·NASDAQ·Life Sciences·CIK 0002088805

Inflection Point Acquisition Corp. VII is a blank check company incorporated on April 3, 2025, as a Cayman Islands exempted company. The company was formed with the sole purpose of completing a Business Combination with one or more businesses or entities. It has the flexibility to pursue an initial Business Combination in any business or industry. To date, the company's activities have been limited to organizational tasks, activities related to its Initial Public Offering, and the search for and consummation of a Business Combination. As of the date of this Report, Inflection Point Acquisition Corp. VII has not yet selected any specific Business Combination target. The company has not generated any operating revenues and does not expect to do so until it completes its initial Business Combination. The company's IPO Registration Statement became effective on January 30, 2026. On February 12, 2026, Inflection Point Acquisition Corp. VII completed its Initial Public Offering of 23,000,000 Units, which included 3,000,000 Option Units issued from the full exercise of the Over-Allotment Option. Each Public Unit consists of one Public Share and one-third of one Public Warrant, with each whole Public Warrant allowing the holder to purchase one Class A Ordinary Share for $11.50 per share. These Public Units were sold at $10.00 per Public Unit, generating gross proceeds of $230,000,000. Concurrently with the IPO closing, the company sold 665,000 Private Placement Units to the Sponsor and the Representatives at $10.00 per unit, generating gross proceeds of $6,650,000. Of these, the Sponsor purchased 265,000 Private Placement Units and the Representatives purchased 400,000 Private Placement Units. A total of $230,000,000, comprising proceeds from both the Initial Public Offering and the Private Placement, was deposited into a Trust Account managed by Continental, acting as trustee.

Inflection Point Acquisition Corp. VII (NASDAQ:IPXG) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for IPXG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-03, rated 7/10. Recent SEC coverage for IPXG spans 425.

Recent high-impact activity:

  • Elroy Air Hits FAA Milestone with Autonomous Cargo Flights Before SPAC Close

Financial Snapshot

Fiscal year ended December 31, 2025
Debt / Equity
0.00×
Source: 10-K · filed 2026-03-30 · accession 0001213900-26-036382
$9.99 -0.06% today
52-week range · as of 2026-09-03 $9.76 – $14.39
Market cap
$315.19M
Volume
9.9K (0.1× avg)
3-mo avg 96.5K
Live data · 2026-09-14 05:54 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed IPXG - Latest Insights

IPXG
Sep 02, 2026, 8:22 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $10.05
Real-time Price: $9.99 info
Change: -$0.055 (-0.55%) info
Market Cap: $315.187M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets